Comparison between a low molecular weight and standard heparin for anticoagulation during extracorporeal CO2 removal in the dog.
Anticoagulant properties towards an artificial surface of a chemically depolymerized low molecular weight heparin (LMWH) have been compared to those of a standard heparin (SH). The experimental model consisted in a seven hours extracorporeal veno-venous bypass for CO2 removal (EC-CO2R) using a membrane lung. Four animals received 150 anti-FXa U/kg followed by 40 anti-FXa U/kg/h of LMWH or 300 IU/kg followed by 100 IU/kg/h of SH. Mean Factor Xa inhibition was 49% in LMWH group and 28.5% in SH group. Mean Factor IIa inhibition was 31% and 49% respectively. After three hours of bypass fibrin deposition occurred in the reservoir in three out of four dogs receiving LMWH while none was observed under SH. No statistically significant difference between the two groups was found for any of the coagulation parameters tested (fibrinogen, factor V, antithrombin III, plasminogen, alpha 2-antiplasmin, platelet counts). At the end of bypass 5000 U protamine abolished both anti-FXa and anti-FIIa activities in the SH group but failed to neutralize more than half of the anti-FXa activity in the LMWH group. These results suggest that high anti-FIIa activities are required to prevent fibrin formation induced by artificial surfaces and that equivalent amounts of anti-FXa activities are ineffective for this purpose. In addition the use of LMWH may raise problems when emergency neutralization procedures are required.
D000818:Animals; D000925:Anticoagulants; D001779:Blood Coagulation Factors / Q000032:analysis; D002245:Carbon Dioxide / Q000097:blood*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005112:Extracorporeal Circulation; D005260:Female; D005337:Fibrin / Q000378:metabolism; D006493:Heparin / Q000145:classification / Q000494:pharmacology*; D006494:Heparin Antagonists / Q000494:pharmacology; D008297:Male; D008970:Molecular Weight; D011479:Protamines / Q000494:pharmacology
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D006494:Heparin Antagonists; D011479:Protamines; D002245:Carbon Dioxide; D005337:Fibrin; D006493:Heparin